GH Research PLC

NASDAQ:GHRS  
20.94
+0.38 (+1.85%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

GH Research PLC Stock, NASDAQ:GHRS

28 Baggot Street Lower, Dublin, Dublin 2
Ireland
Phone: +353.1.437.8443
Number of Employees:
http://www.ghres.com

Description

GH Research Plc operates as a holding company which through its subsidiaries provides biopharmaceutical products and services. It develops therapeutic products for the patients who are suffering from Treatment Resistant Depression (TRD). The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Sch�¶nharting and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.